Red Tree Venture Capital is an early stage-biased life science venture firm that employs a targeted strategy of leveraging its deep relationships with leading West Coast academic and research institutions to source innovation emerging from those organizations. The firm closed its inaugural fund, Red Tree Venture Capital Fund I, in 2022, raising a total of $272 million to create and/or invest in life science companies that are advancing transformative science.

Our team pairs a proven ability to translate scientific innovation into successful businesses with unique access to premier West Coast academic luminaries and scientific entrepreneurs. This combination strongly positions Red Tree Venture Capital to establish itself as the partner-of-choice for West Coast entrepreneurs and scientists looking to create and build impactful life science companies.